The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
Open accessAbstract
Recent cross species transmission of avian influenza has highlighted the threat of pandemic influenza. Oseltamivir (Tamiflu) has been shown to be effective in the treatment and prevention of epidemic influenza infection in adults, adolescents and children (> or = 1 year). Although oseltamivir has not been approved for prophylactic use in children, it has been shown to be effective. Oseltamivir is also active against avian influenza virus strains. Evidence suggests that lower doses or shorter durations of treatment/chemoprophylaxis other than those approved may not be effective and may contribute to emergence of viral resistance. Safety data from dose ranging studies show that 5 day courses of 150 mg twice daily for treatment and 6 week courses of 75 mg twice daily for prophylaxis were as well tolerated as the approved dose regimens. The use of oseltamivir in a pandemic is influenced by the goals of the pandemic plan developed by the responsible Government and Health Authority. To optimize use of antiviral medications, processes will be needed to collect, collate and report outcome data from treated patients and/or from use for chemoprophylaxis of pandemic influenza during the first-wave outbreaks. If oseltamivir is included in a national or regional pandemic plan, stockpiling of the material, either in the form of capsules or the bulk active pharmaceutical ingredient will be necessary. In the absence of a stockpile, there is no guarantee that an adequate supply of oseltamivir will be available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,415
Treanor, J. J., Hayden, F. G., Vrooman, P. S., Barbarash, R., Bettis, R., Riff, D., Singh, S., Kinnersley, N., Ward, P., Mills, R. G., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1016 · Cited by 1,014
Self-citationAvian Influenza A (H5N1) in 10 Patients in Vietnam
Hien, T. T., Liem, N. T., Dung, N. T., San, L. T., Mai, P. P., Chau, N. V. V., Suu, P. T., Dong, V. C., Mai, L. T. Q., Thi, N. T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040419 · Cited by 839
Koopmans, M., Wilbrink, B., Conyn, M., Natrop, G., van der Nat, H., Vennema, H., Meijer, A., van Steenbergen, J., Fouchier, R., Osterhaus, A., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15589-x · Cited by 837
Potier, M., Mameli, L., Bélisle, M., Dallaire, L., & Melançon, S. B. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90362-2 · Cited by 815
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) · Virology · doi:10.1016/0042-6822(74)90276-1 · Cited by 789
Resistant influenza A viruses in children treated with oseltamivir: descriptive study
Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N., & Kawaoka, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16934-1 · Cited by 786
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
Nicholson, K., Aoki, F., Osterhaus, A., Trottier, S., Carewicz, O., Mercier, C., Rode, A., Kinnersley, N., & Ward, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02288-1 · Cited by 785
Self-citationHayden, F. G., Osterhaus, A. D. M. E., Treanor, J. J., Fleming, D. M., Aoki, F. Y., Nicholson, K. G., Bohnen, A. M., Hirst, H. M., Keene, O., & Wightman, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371302 · Cited by 762
Initial Genetic Characterization of the 1918 “Spanish” Influenza Virus
Taubenberger, J. K., Reid, A. H., Krafft, A. E., Bijwaard, K. E., & Fanning, T. G. (1997) · Science · doi:10.1126/science.275.5307.1793 · Cited by 715
Oral oseltamivir treatment of influenza in children
WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711
Self-citationContaining Pandemic Influenza with Antiviral Agents
Longini, I. M. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh092 · Cited by 705
Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A., & Klenk, H.-D. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12665-12667.2004 · Cited by 606
Potter, C. W. (2001) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2001.01492.x · Cited by 584
Impact of Respiratory Virus Infections on Persons With Chronic Underlying Conditions
Glezen, W. P. (2000) · JAMA · doi:10.1001/jama.283.4.499 · Cited by 559
Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza
Hayden, F. G., Atmar, R. L., Schilling, M., Johnson, C., Poretz, D., Paar, D., Huson, L., Ward, P., & Mills, R. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910283411802 · Cited by 512
Self-citationBurden of Interpandemic Influenza in Children Younger than 5 Years: A 25‐Year Prospective Study
Neuzil, K. M., Zhu, Y., Griffin, M. R., Edwards, K. M., Thompson, J. M., Tollefson, S. J., & Wright, P. F. (2002) · The Journal of Infectious Diseases · doi:10.1086/338363 · Cited by 503
Kaiser, L., Wat, C., Mills, T., Mahoney, P., Ward, P., & Hayden, F. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1667 · Cited by 501
Self-citationINFLUENZA OCCURRING IN PREGNANT WOMEN: A STATISTICAL STUDY OF THIRTEEN HUNDRED AND FIFTY CASES
HARRIS, J. W. (1919) · Journal of the American Medical Association · doi:10.1001/jama.1919.02610140008002 · Cited by 468
Welliver, R. (2001) · JAMA · doi:10.1001/jama.285.6.748 · Cited by 463
Clements, M. L., Betts, R. F., Tierney, E. L., & Murphy, B. R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.1.157-160.1986 · Cited by 435
Early administration of oral oseltamivir increases the benefits of influenza treatment
Aoki, F. Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg007 · Cited by 424
Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families
Hayden, F. G., Belshe, R. B., Clover, R. D., Hay, A. J., Oakes, M. G., & Soo, W. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212502 · Cited by 416
Ives, J. A. L., Carr, J. A., Mendel, D. B., Tai, C. Y., Lambkin, R., Kelly, L., Oxford, J. S., Hayden, F. G., & Roberts, N. A. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00053-0 · Cited by 379
Pathogenesis of Avian Influenza A (H5N1) Viruses in Ferrets
Zitzow, L. A., Rowe, T., Morken, T., Shieh, W.-J., Zaki, S., & Katz, J. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4420-4429.2002 · Cited by 354
Deaths from Asian influenza associated with pregnancy
Freeman, D. W., & Barno, A. (1959) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(59)90570-8 · Cited by 337
Hayden, F. G., Belshe, R., Villanueva, C., Lanno, R., Hughes, C., Small, I., Dutkowski, R., Ward, P., & Carr, J. (2004) · The Journal of Infectious Diseases · doi:10.1086/381128 · Cited by 334
Self-citationResistance of influenza viruses to neuraminidase inhibitors — a review
MCKIMMBRESCHKIN, J. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00103-0 · Cited by 320
Influenza Viruses Resistant to the Antiviral Drug Oseltamivir: Transmission Studies in Ferrets
Herlocher, M. L., Truscon, R., Elias, S., Yen, H., Roberts, N. A., Ohmit, S. E., & Monto, A. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/424572 · Cited by 292
McKimm-Breschkin, J., Trivedi, T., Hampson, A., Hay, A., Klimov, A., Tashiro, M., Hayden, F., & Zambon, M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2264-2272.2003 · Cited by 291
Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase
Kilbourne, E. D., Laver, W. G., Schulman, J. L., & Webster, R. G. (1968) · Journal of Virology · doi:10.1128/jvi.2.4.281-288.1968 · Cited by 273
Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine
Couch, R. B., Kasel, J. A., Gerin, J. L., Schulman, J. L., & Kilbourne, E. D. (1974) · Journal of Infectious Diseases · doi:10.1093/infdis/129.4.411 · Cited by 257
Li, K. S., Xu, K. M., Peiris, J. S. M., Poon, L. L. M., Yu, K. Z., Yuen, K. Y., Shortridge, K. F., Webster, R. G., & Guan, Y. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6988-6994.2003 · Cited by 257
Govorkova, E. A., Leneva, I. A., Goloubeva, O. G., Bush, K., & Webster, R. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2723-2732.2001 · Cited by 240
Influenza virus infections in infants
GLEZEN, W. P., TABER, L. H., FRANK, A. L., GRUBER, W. C., & PIEDRA, P. A. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199711000-00012 · Cited by 239
Irving, W. L., James, D. K., Stephenson, T., Laing, P., Jameson, C., Oxford, J. S., Chakraverty, P., Brown, D. W. G., Boon, A. C. M., & Zambon, M. C. (2000) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11621.x · Cited by 235
OXFORD, J. S. (2000) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(200003/04)10:2<119::aid-rmv272>3.0.co;2-o · Cited by 223
Influenza-Associated Morbidity and Mortality in Young and Middle-Aged Women
Neuzil, K. M., Reed, G. W., Mitchel, Jr., & Griffin, M. R. (1999) · JAMA · doi:10.1001/jama.281.10.901 · Cited by 222
Glezen, W. P., Decker, M., & Perrotta, D. M. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.3.550 · Cited by 204
Long‐Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population
Peters, P. H., Gravenstein, S., Norwood, P., De Bock, V., Van Couter, A., Gibbens, M., Von Planta, T., & Ward, P. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49204.x · Cited by 190
Self-citationThe epidemiology and clinical impact of pandemic influenza
Nguyen-Van-Tam, J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00069-0 · Cited by 187
Carr, J., Ives, J., Kelly, L., Lambkin, R., Oxford, J., Mendel, D., Tai, L., & Roberts, N. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00215-7 · Cited by 175
Leneva, I. A., Roberts, N., Govorkova, E. A., Goloubeva, O. G., & Webster, R. G. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00123-6 · Cited by 167
Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets
Herlocher, M. L., Carr, J., Ives, J., Elias, S., Truscon, R., Roberts, N. A., & Monto, A. S. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00214-5 · Cited by 158
Position statement: global neuraminidase inhibitor susceptibility network
Zambon, M. C. F. A., & Hayden, F. G. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00124-3 · Cited by 153
Tai, C. Y., Escarpe, P. A., Sidwell, R. W., Williams, M. A., Lew, W., Wu, H., Kim, C. U., & Mendel, D. B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3234 · Cited by 147
Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999–2000
Bowles, S. K., Lee, W., Simor, A. E., Vearncombe, M., Loeb, M. B., Tamblyn, S. E., Fearon, M. A., Li, Y., McGeer, A., & The Oseltamivir Compassionate Use Program Group (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50153.x · Cited by 143
Calfee, D. P., Peng, A., Cass, L., Lobo, M., & Hayden, F. G. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1616 · Cited by 135
Influenza Virus: a Master of Metamorphosis
de Jong, J. C., Rimmelzwaan, G. F., Fouchier, R. A. M., & Osterhaus, A. D. M. E. (2000) · Journal of Infection · doi:10.1053/jinf.2000.0652 · Cited by 131
Transplacental Transfer of Influenza Virus
Yawn, D. H. (1971) · JAMA · doi:10.1001/jama.1971.03180320064016 · Cited by 130
Pathology of Human Influenza A (H5N1) Virus Infection in Cynomolgus Macaques (Macaca fascicularis)
Kuiken, T., Rimmelzwaan, G. F., van Amerongen, G., & Osterhaus, A. D. M. E. (2003) · Veterinary Pathology · doi:10.1354/vp.40-3-304 · Cited by 128
Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus
Tumpey, T. M., García‐Sastre, A., Mikulasova, A., Taubenberger, J. K., Swayne, D. E., Palese, P., & Basler, C. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519699 · Cited by 127
How to overcome resistance of influenza A viruses against adamantane derivatives
Scholtissek, C., Quack, G., Klenk, H., & Webster, R. G. (1998) · Antiviral Research · doi:10.1016/s0166-3542(97)00061-2 · Cited by 125
Emergence of Drug Resistance during an Influenza Epidemic: Insights from a Mathematical Model
Stilianakis, N. I., Perelson, A. S., & Hayden, F. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/515246 · Cited by 125
Safety and Pharmacology of Oseltamivir in Clinical Use
Dutkowski, R. T., Thakrar, B. T., Froehlich, E., Suter, P., Oo, C., & Ward, P. (2003) · Drug Safety · doi:10.2165/00002018-200326110-00004 · Cited by 123
Self-citationDetection and Control of Influenza Outbreaks in Well-Vaccinated Nursing Home Populations
Monto, A. S., Rotthoff, J. R., Teich, E., Herlocher, M. L., Truscon, R., Yen, H., Elias, S., & Ohmit, S. E. (2004) · Clinical Infectious Diseases · doi:10.1086/422646 · Cited by 123
Risk of acute respiratory disease among pregnant women during influenza A epidemics.
Mullooly, J. P., Barker, W. H., & Nolan, T. F. (1986) · PubMed · Cited by 118
Ferguson, N. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg136 · Cited by 117
Perspectives on antiviral use during pandemic influenza
Hayden, F. G. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.1007 · Cited by 109
Plasminogen-Binding Activity of Neuraminidase Determines the Pathogenicity of Influenza A Virus
Goto, H., Wells, K., Takada, A., & Kawaoka, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9297-9301.2001 · Cited by 104
Use of Oseltamivir to control influenza complications after bone marrow transplantation
Machado, C. M., Boas, L. S. V., Mendes, A. V. A., da Rocha, I. F., Sturaro, D., Dulley, F. L., & Pannuti, C. M. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704534 · Cited by 99
Treatment of influenza with neuraminidase inhibitors: virological implications
Roberts, N. A. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.1002 · Cited by 63
Oseltamivir-resistant influenza?
Moscona, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16947-x · Cited by 50
Experience with oseltamivir in the control of a nursing home influenza B outbreak.
Parker, R., Loewen, N., & Skowronski, D. M. (2001) · PubMed · Cited by 41
Clinical Benefits with Oseltamivir in???Treating Influenza in Adult Populations
Singh, S., Barghoorn, J., Bagdonas, A., Adler, J., Treanor, J. J., Kinnersley, N., & Ward, P. (2003) · Clinical Drug Investigation · doi:10.2165/00044011-200323090-00002 · Cited by 40
Self-citationChik, K. ‐., Li, C. K., Pk, C., Mm, S., Lee, V., Tam, J., & Pm, Y. (2004) · PubMed · Cited by 38
Experience with Oseltamivir in the Control of Nursing Home Influenza A Outbreak.
Shijubo, N., Yamada, G., Takahashi, M., Tokunoh, T., Suzuki, T., & Abe, S. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.366 · Cited by 23
Skin Reactions in Patients with Influenza Treated with Oseltamivir: A Retrospective Cohort Study
Nordstrom, B. L., Oh, K., Sacks, S. T., & L'Italien, G. J. (2004) · Antiviral Therapy · doi:10.1177/135965350400900217 · Cited by 17
A Surveillance System for the Real-Time Reporting of Influenza Activity
Uphoff, H., Groniewicz, I., Soriano, M., & Burckhardt-Batista, I. (2004) · Disease Management & Health Outcomes · doi:10.2165/00115677-200412030-00006 · Cited by 1
Cited by
H1N1 2009 influenza virus infection during pregnancy in the USA
Jamieson, D. J., Honein, M. A., Rasmussen, S. A., Williams, J. L., Swerdlow, D. L., Biggerstaff, M. S., Lindstrom, S., Louie, J. K., Christ, C. M., Bohm, S. R., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61304-0 · Cited by 1,361
Avian Influenza A (H5N1) Infection in Humans
(2005) · New England Journal of Medicine · doi:10.1056/nejmra052211 · Cited by 1,285
Avian Influenza Virus (H5N1): a Threat to Human Health
Peiris, J. S. M., de Jong, M. D., & Guan, Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-06 · Cited by 1,007
Oseltamivir Resistance during Treatment of Influenza A (H5N1) Infection
de Jong, M. D., Thanh, T. T., Khanh, T. H., Hien, V. M., Smith, G. J. D., Chau, N. V., Cam, B. V., Qui, P. T., Ha, D. Q., Guan, Y., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa054512 · Cited by 901
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Russell, R. J., Haire, L. F., Stevens, D. J., Collins, P. J., Lin, Y. P., Blackburn, G. M., Hay, A. J., Gamblin, S. J., & Skehel, J. J. (2006) · Nature · doi:10.1038/nature05114 · Cited by 813
Metadata
- Authors
- Ward, P., Small, I., Smith, J., Suter, P., & Dutkowski, R.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-02-01
- Volume
- 55
- Issue
- suppl_1
- Pages
- i5-i21
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2117004115
- Cited by
- 428
- References
- 69
- FWCI
- 27.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.